My Cart

Siglec-8

Siglec-8 Overview

English NameSialic acid-binding Ig-like lectin 8Approved Drugs0
Drugs in Clinical Trials2Target SynonymSialic acid-binding Ig-like lectin 8,SIGLEC8,SAF2,Sialoadhesin family member 2,SAF-2,Sialic Acid Binding Ig Like Lectin 8,Sialic Acid Binding Ig-Like Lectin 8,SIGLEC8L,Siglec-8,MGC59785
Highest Development StagePhase 3 Clinical
English NameSialic acid-binding Ig-like lectin 8
Target SynonymSialic acid-binding Ig-like lectin 8,SIGLEC8,SAF2,Sialoadhesin family member 2,SAF-2,Sialic Acid Binding Ig Like Lectin 8,Sialic Acid Binding Ig-Like Lectin 8,SIGLEC8L,Siglec-8,MGC59785
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 3 Clinical

Siglec-8 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (3)

  • Tag

    His Tag (1)Fc Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (2)Biotin-labeled (1)

Siglec-8 Background

Siglec-8 is also known as SIGLEC8, SAF2, SIGLEC-8, SIGLEC8L and sialic acid binding Ig like lectin 8. Siglec-8 was first identified by CD33 homology screening of ESTs from a cDNA library generated from a patient diagnosed with idiopathic hypereosinophilic syndrome and was originally termed SAF-2 (sialoadhesin family 2). At the tissue level, Siglec-8 mRNA was found to be most highly expressed in lung, PBMCs, spleen, and kidney. Two splice variants of Siglec-8 exist. The initially characterized form contains 431 amino acid residues in total, subsequently, a longer form of Siglec-8, initially termed Siglec-8L. Both forms of Siglec-8 are found in eosinophils and contain a V-set domain with lectin activity and two C2-type Ig repeat domains in the extracellular region.

Siglec-8 Synonyms

Siglec-8,SAF-2,SIGLEC8,SAF2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
AK-001AK-001Phase 3 ClinicalAllakos IncRespiratory Tract Infections; Nasal Polyps; Urinary Tract Infections; Community Acquired Pneumonia; Hypersensitivity
Details
LirentelimabAK-002; AK 002Phase 2 ClinicalJohns Hopkins University School Of MedicineEosinophilic gastroenteritis (EG); Chronic Urticaria; Mastocytosis, Systemic; Conjunctivitis, Allergic; Eosinophilic Esophagitis; Duodenitis; Keratoconjunctivitis; Dermatitis, Atopic
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland